Literature DB >> 15964962

The emergence of west nile virus during a large outbreak in Illinois in 2002.

Gregory D Huhn1, Connie Austin, Carl Langkop, Kate Kelly, Roland Lucht, Richard Lampman, Robert Novak, Linn Haramis, Rosemary Boker, Stephanie Smith, Maria Chudoba, Susan Gerber, Craig Conover, Mark S Dworkin.   

Abstract

In 2002, the world's largest outbreak of neuroinvasive West Nile virus (WNV) disease occurred. Illinois reported 21% of the total cases in the United States, the most among all states. The epidemiology of WNV in Illinois in 2002 was examined to determine factors associated with severe disease and death. A total of 884 cases were identified and there were 66 deaths. The overall attack rate of WNV infection was 7.1 per 100,000 population and this increased with age. The median ages of patients and patients who died were 56 and 78 years, respectively. Among patients who died, 91% were diagnosed with encephalitis and the case-fatality rate for patients with encephalitis was 18.6%. Patients more than 50 years old had a significantly higher risk of being reported with encephalitis (relative risk [RR] = 3.3, 95% confidence interval [CI] = 2.6-4.3%) and death (RR = 22.3, 95% CI = 5.5-90.4%). Clinicians evaluating elderly patients with WNV infection should assess patients closely for progression of disease.

Entities:  

Mesh:

Year:  2005        PMID: 15964962

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

1.  PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons.

Authors:  Melanie A Samuel; Kevin Whitby; Brian C Keller; Anantha Marri; Winfried Barchet; Bryan R G Williams; Robert H Silverman; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  Weather variability affects abundance of larval Culex (Diptera: Culicidae) in storm water catch basins in suburban Chicago.

Authors:  Allison M Gardner; Gabriel L Hamer; Alicia M Hines; Christina M Newman; Edward D Walker; Marilyn O Ruiz
Journal:  J Med Entomol       Date:  2012-03       Impact factor: 2.278

3.  Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 4.  The structural immunology of antibody protection against West Nile virus.

Authors:  Michael S Diamond; Theodore C Pierson; Daved H Fremont
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

Review 5.  Progress on the development of therapeutics against West Nile virus.

Authors:  Michael S Diamond
Journal:  Antiviral Res       Date:  2009-06-06       Impact factor: 5.970

6.  Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis.

Authors:  Melanie A Samuel; Hong Wang; Venkatraman Siddharthan; John D Morrey; Michael S Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-15       Impact factor: 11.205

7.  Challenges to Mitigating the Urban Health Burden of Mosquito-Borne Diseases in the Face of Climate Change.

Authors:  Antonio Ligsay; Olivier Telle; Richard Paul
Journal:  Int J Environ Res Public Health       Date:  2021-05-10       Impact factor: 3.390

Review 8.  Immune responses to West Nile virus infection in the central nervous system.

Authors:  Hyelim Cho; Michael S Diamond
Journal:  Viruses       Date:  2012-12-17       Impact factor: 5.048

9.  Terrestrial vegetation and aquatic chemistry influence larval mosquito abundance in catch basins, Chicago, USA.

Authors:  Allison M Gardner; Tavis K Anderson; Gabriel L Hamer; Dana E Johnson; Kate E Varela; Edward D Walker; Marilyn O Ruiz
Journal:  Parasit Vectors       Date:  2013-01-11       Impact factor: 3.876

10.  Examination of the geographical variation in human West Nile virus: a spatial filtering approach.

Authors:  J Tevie; A Bohara; R B Valdez
Journal:  Epidemiol Infect       Date:  2014-02-06       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.